The Bergen COVID-19 Research: Pioneering Research That Shapes Policy
Our group is a dynamic team of scientists dedicated to unraveling the complexities of COVID-19. Beyond researchers, we are an important link between science and society.
Our group is a dynamic team of scientists dedicated to unraveling the complexities of COVID-19. Beyond researchers, we are an important link between science and society.
➢ Our Impact: Guiding Global Responses
Our early findings have significantly influenced national and international COVID-19 policies. From reducing transmission in households to uncovering long COVID in mild cases, our research aids decision-makers.
➢ Vaccine Insights: Protecting Communities
Our clinical trials on COVID-19 vaccine responses has played a pivotal role in understanding immunity. We've identified the need for booster shots in high risk groups, particularly with the emergence of variants like Delta and Omicron, ensuring enhanced protection for all.
➢ Educating the Public: Sharing Knowledge
Our contributions extend beyond groundbreaking research. We actively educate students, scientists, and healthcare workers through webinars and public engagement initiatives, both locally, nationally and on the global stage.
➢ Connecting with Communities: Trustworthy Outreach
We serve as a trusted source of scientific knowledge in the media, providing clarity amid uncertainty. Our online presence, including our dedicated website and public engagement initiatives, reaches diverse audiences.
➢ Policy Advice: Guiding Key Organizations
Our experts advise influential organizations, including the WHO, EU and the European Commission. We've contributed to shaping public health strategies, including scientific opinions on pandemics.
Future-Ready: Prepared for What Lies Ahead
Our multidisciplinary team is well-prepared to tackle future outbreaks, epidemics, and pandemics. With ongoing projects and a commitment to pandemic preparedness, we're poised to meet the challenges of tomorrow.
Explore our ongoing research and discoveries as we continue our mission to understand COVID-19 and contribute to a safer world.
Gruppemedlemmer
Rebecca Jane Cox Brokstad
Professor, PhD. PI og leder for Influensasenteret
Nina Langeland
Professor, MD, PhD, Medisinsk PI
Kristin Greve-Isdahl Mohn
Førsteamanuensis, MD, PhD. Spesialist i infeksjonsmedisin
Bjørn Blomberg
Førsteamanuensis, MD, PhD. Spesialist i infeksjonsmedisin
Karl A. Brokstad
Professor, Dr. Sc. Immunolog og labkoordinator
Andre gruppemedlemmer
Arild Iversen (Bergen Municipality)
Kjell Haug (Bergen Municipality, Department of Global Public Health and Primary Care (IGS))
Bård Kittang (Department of Clinical Science (K2), Bergen Municipality, Haraldsplass Deaconess Hospital (HDS))
Dagrun Waag Linchhausen
Iren Löhr (K2, Stavanger University Hospital (SUS))
Heidi Syre (SUS)
Marianne Sævik (Haukeland University Hospital (HUS))
Fan Zhou (K2)